The gold standard of thyroid nodule examination? Prospective validation of the ACR TI-RADS in a secondary referral center
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
33094631
PubMed Central
PMC8603730
DOI
10.33549/physiolres.934515
PII: 934515
Knihovny.cz E-zdroje
- MeSH
- centra sekundární péče normy MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory štítné žlázy diagnóza diagnostické zobrazování chirurgie MeSH
- prospektivní studie MeSH
- referenční standardy MeSH
- štítná žláza diagnostické zobrazování patologie chirurgie MeSH
- tenkojehlová biopsie MeSH
- ultrasonografie metody MeSH
- uzly štítné žlázy diagnóza diagnostické zobrazování chirurgie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
The aim of this prospective study was the validation of the risk stratification of thyroid nodules using ultrasonography with the American College of Radiology Thyroid Imaging, Reporting and Data System (ACR TI-RADS) and partly in comparison to American Thyroid Association (ATA) guidelines in a secondary referral center. Fine needle aspiration biopsy (FNA) (n=605) and histological examinations (n=63) were the reference standards for the statistical analysis. ACR TI-RADS cut-off value: TR4 with sensitivity 85.7 %, specificity 54.1 %, PPV 58.5 %, accuracy 67.7 % (AUC 0.738; p<0.001). ATA cut-off value: "high suspicion" with sensitivity 80 %, specificity 83.3 %, PPV 80 %, accuracy 81.8 % (AUC 0.800; p=0.0025). 18.4 % nodules (3 malignant) could not be assigned to a proper ATA US pattern group (p<0.0001). Both ACR TI-RADS and ATA have allowed fair selection of nodules requiring FNA with superiority of ACR TI-RADS according to classification of all thyroid nodules to the proper group. According to ACR TI-RADS almost one third of the patients were incorrectly classified with 17.9 % missed thyroid carcinomas, exclusively micropapillary carcinomas, even though, the amount of FNA would be reduced to 48 %.
Zobrazit více v PubMed
AHN HS, KIM HJ, KIM KH, LEE YS, HAN SJ, KIM Y, KO MJ, BRITO JP. Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality. Thyroid. 2016;26:1535–1540. doi: 10.1089/thy.2016.0075. PubMed DOI
BILEK R, CEROVSKA J, ZAMRAZIL V. The relationship between iodine intake and serum thyroglobulin in the general population. Physiol Res. 2015;64:345–353. doi: 10.33549/physiolres.932840. PubMed DOI
BILEK R, DVORAKOVA M, GRIMMICHOVA T, JISKRA J. Iodine, thyroglobulin and thyroid gland. Physiol Res. 2020;69(Suppl 2):S225–S236. doi: 10.33549/physiolres.934514. PubMed DOI PMC
CIBAS ES, ALI SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27:1341–1346. doi: 10.1089/thy.2017.0500. PubMed DOI
GRANT EG, TESSLER FN, HOANG JK, LANGER JE, BELAND MD, BERLAND LL, CRONAN JJ, DESSER TS, FRATES MC, HAMPER UM, MIDDLETON WD, READING CC, SCOUTT LM, STAVROS AT, TEEFEY SA. Thyroid ultrasound reporting lexicon: White Paper of the ACR Thyroid Imaging, Reporting and Data System (TIRADS) Committee. J Am Coll Radiol. 2015;12:1272–1279. doi: 10.1016/j.jacr.2015.07.011. PubMed DOI
GUTH S, THEUNE U, ABERLE J, GALACH A, BAMBERGER CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest. 2009;39:699–706. doi: 10.1111/j.1365-2362.2009.02162.x. PubMed DOI
HAUGEN BR, ALEXANDER EK, BIBLE KC, DOHERTY GM, MANDEL SJ, NIKIFOROV YE, PACINI F, RANDOLPH GW, SAWKA AM, SCHLUMBERGER M, SCHUFF KG, SHERMAN SI, SOSA JA, STEWARD DL, TUTTLE RM, WARTOFSKY L. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133. doi: 10.1089/thy.2015.0020. PubMed DOI PMC
HORVATH E, SILVA CF, MAJLIS S, RODRIGUEZ I, SKOKNIC V, CASTRO A, ROJAS H, NIEDMANN JP, MADRID A, CAPDEVILLE F, WHITTLE C, ROSSI R, DOMÍNGUEZ M, TALA H. Prospective validation of the ultrasound based TIRADS (Thyroid Imaging Reporting And Data System) classification: results in surgically resected thyroid nodules. Eur Radiol. 2017;27:2619–2621. doi: 10.1007/s00330-016-4605-y. PubMed DOI
KIM EK, PARK CS, CHUNG WY, OH KK, KIM DI, LEE JT, YOO HS. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am J Roentgenol. 2002;178:687–691. doi: 10.2214/ajr.178.3.1780687. PubMed DOI
KRATKY J, VITKOVA H, BARTAKOVA J, TELICKA Z, ANTOSOVA M, LIMANOVA Z, JISKRA J. Thyroid nodules: pathophysiological insight on oncogenesis and novel diagnostic techniques. Physiol Res. 2014;63(Suppl 2):S263–S275. doi: 10.33549/physiolres.932818. PubMed DOI
LASITHIOTAKIS K, GRISBOLAKI E, KOUTSOMANOLIS D, VENIANAKI M, PETRAKIS I, VRACHASSOTAKIS N, CHRYSOS E, ZORAS O, CHALKIADAKIS G. Indications for surgery and significance of unrecognized cancer in endemic multinodular goiter. World J Surg. 2012;36:1286–1292. doi: 10.1007/s00268-012-1554-8. PubMed DOI
LAURIA PANTANO A, MADDALONI E, BRIGANTI SI, BERETTA ANGUISSOLA G, PERRELLA E, TAFFON C. Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules. Eur J Endocrinol. 2018;178:595–603. doi: 10.1530/eje-18-0083. PubMed DOI
MELOUN M, HILL M, MILITKÝ J, KUPKA K. Transformation in the PC-aided biochemical data analysis. Clin Chem Lab Med. 2000;38:553–559. doi: 10.1515/cclm.2000.081. PubMed DOI
MELOUN M, MILITKÝ J, HILL M, BRERETON RG. Crucial problems in regression modelling and their solutions. Analyst. 2002;127:433–450. doi: 10.1039/b110779h. PubMed DOI
MIDDLETON WD, TEEFEY SA, READING CC, LANGER JE, BELAND MD, SZABUNIO MM. Comparison of performance characteristics of American College of Radiology TI-RADS, Korean Society of Thyroid Radiology TIRADS, and American Thyroid Association guidelines. AJR Am J Roentgenol. 2018;210:1148–1154. doi: 10.2214/ajr.17.18822. PubMed DOI
NABHAN F, RINGEL MD. Thyroid nodules and cancer management guidelines: comparisons and controversies. Endocr Relat Cancer. 2017;24:13–26. doi: 10.1530/erc-16-0432. PubMed DOI PMC
NGUYEN XV, ROY CHOUDHURY K, TESSLER FN, HOANG JK. Effect of tumor size on risk of metastatic disease and survival for thyroid cancer: implications for biopsy guidelines. Thyroid. 2018;28:295–300. doi: 10.1089/thy.2017.0526. PubMed DOI
ROTI E, Degli UBERTI EC, BONDANELLI M, BRAVERMAN LE. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol. 2008;159:659–673. doi: 10.1530/eje-07-0896. PubMed DOI
RUSS G. Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography. 2016;35:25–38. doi: 10.14366/usg.15027. PubMed DOI PMC
RUSS G, BONNEMA SJ, ERDOGAN MF, DURANTE C, NGU R, LEENHARDT L. European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J. 2017;6:225–237. doi: 10.1159/000478927. PubMed DOI PMC
SINGH O, SPINA N, MARAKA S, ESPINOS A, DEYCAZA A, O'KEEFFE D, BRITO JP, GIONFRIDDO MR, CASTRO MR, MORRIS JC, ERWIN P, MONTORI VM. Diagnostic accuracy of thyroid nodule growth to predict malignancy in thyroid nodules with benign cytology: systematic review and meta-analysis. Clin Endocrinol (Oxf) 2016;85:122–131. doi: 10.1111/cen.12975. PubMed DOI
TESSLER FN, MIDDLETON WD, GRANT EG, HOANG JK, BERLAND LL, TEEFEY SA, CRONAN JJ, BELAND MD, DESSER TS, FRATES MC, HAMMERS LW, HAMPER UM, LANGER JE, READING CC, SCOUTT LM, STAVROS AT. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14:587–595. doi: 10.1016/j.jacr.2017.01.046. PubMed DOI
TUTTLE RM, WARTOFSKY L. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133. doi: 10.18508/endo5102. PubMed DOI PMC
VACCARELLA S, FRANCESCHI S, BRAY F, WILD CP, PLUMMER M, Dal MASO L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375:614–617. PubMed
YOON JH, LEE HS, KIM EK, MOON HJ, KWAK JY. Malignancy risk stratification of thyroid nodules: comparison between the Thyroid Imaging Reporting and Data System and the 2014 American Thyroid Association management guidelines. Radiology. 2016;278:917–924. doi: 10.1148/radiol.2015150056. PubMed DOI